27.6 2,364 89.8 1,742 Analysis, 2nd Q nd (“the Compa ancial statem ending 30 J marized as f nancial state cond quarter erformance o the six-mont x-month per the second r was as a re e performanc roperty

A 7, 2018 as fo pendent Di place. Mr.Su n and Appo sets of the Co Performanc siness Restru mpany Limi s passed sig airman of th d Chairman Audit Comm ollows: irector and umate Sang ointment ompany ce

A 7, 2018 as fo pendent Di place. Mr.Su n and Appo sets of the Co Performanc siness Restru mpany Limi s passed sig airman of th d Chairman Audit Comm ollows: irector and umate Sang ointment ompany ce

A 7, 2018 as fo pendent Di place. Mr.Su n and Appo sets of the Co Performanc siness Restru mpany Limi s passed sig airman of th d Chairman Audit Comm ollows: irector and umate Sang ointment ompany ce